The DOI matches its Crossref record; 205 of the 205 references it cites were found in a registry or an index.
Hepatocellular carcinoma: updates on epidemiology, surveillance, diagnosis and treatment
Open accessAbstract
Hepatocellular carcinoma (HCC) is a major global burden, ranking as the third leading cause of cancer-related mortality. HCC due to chronic hepatitis B virus (HBV) or C virus (HCV) infection has decreased due to universal vaccination for HBV and effective antiviral therapy for both HBV and HCV, but HCC related to metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease is increasing. Biannual liver ultrasonography and serum α-fetoprotein are the primary surveillance tools for early HCC detection among high-risk patients (e.g., cirrhosis, chronic HBV). Alternative surveillance tools such as blood-based biomarker panels and abbreviated magnetic resonance imaging (MRI) are being investigated. Multiphasic computed tomography or MRI is the standard for HCC diagnosis, but histological confirmation should be considered, especially when inconclusive findings are seen on cross-sectional imaging. Staging and treatment decisions are complex and should be made in multidisciplinary settings, incorporating multiple factors including tumor burden, degree of liver dysfunction, patient performance status, available expertise, and patient preferences. Early-stage HCC is best treated with curative options such as resection, ablation, or transplantation. For intermediate-stage disease, locoregional therapies are primarily recommended although systemic therapies may be preferred for patients with large intrahepatic tumor burden. In advanced-stage disease, immune checkpoint inhibitor-based therapy is the preferred treatment regimen. In this review article, we discuss the recent global epidemiology, risk factors, and HCC care continuum encompassing surveillance, diagnosis, staging, and treatments.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., & Bray, F. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21660 · Cited by 108,699
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
Galle, P. R., Forner, A., Llovet, J. M., Mazzaferro, V., Piscaglia, F., Raoul, J.-L., Schirmacher, P., & Vilgrain, V. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.03.019 · Cited by 11,406
Atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma
Finn, R. S., Qin, S., Ikeda, M., Galle, P. R., Ducreux, M., Kim, T.-Y., Kudo, M., Breder, V., Merle, P., Kaseb, A. O., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa1915745 · Cited by 7,470
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Llovet, J. M., Kelley, R. K., Villanueva, A., Singal, A. G., Pikarsky, E., Roayaie, S., Lencioni, R., Koike, K., Zucman-Rossi, J., & Finn, R. S. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-00240-3 · Cited by 7,055
Self-citationKudo, M., Finn, R. S., Qin, S., Han, K.-H., Ikeda, K., Piscaglia, F., Baron, A., Park, J.-W., Han, G., Jassem, J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30207-1 · Cited by 5,497
Marrero, J. A., Kulik, L. M., Sirlin, C. B., Zhu, A. X., Finn, R. S., Abecassis, M. M., Roberts, L. R., & Heimbach, J. K. (2018) · Hepatology · doi:10.1002/hep.29913 · Cited by 4,539
BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update
Reig, M., Forner, A., Rimola, J., Ferrer-Fàbrega, J., Burrel, M., Garcia-Criado, Á., Kelley, R. K., Galle, P. R., Mazzaferro, V., Salem, R., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2021.11.018 · Cited by 4,319
Self-citationA global view of hepatocellular carcinoma: trends, risk, prevention and management
Yang, J. D., Hainaut, P., Gores, G. J., Amadou, A., Plymoth, A., & Roberts, L. R. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0186-y · Cited by 4,228
Self-citationBruix, J., Qin, S., Merle, P., Granito, A., Huang, Y.-H., Bodoky, G., Pracht, M., Yokosuka, O., Rosmorduc, O., Breder, V., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(16)32453-9 · Cited by 3,653
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Younossi, Z. M., Golabi, P., Paik, J. M., Henry, A., Van Dongen, C., & Henry, L. (2023) · Hepatology · doi:10.1097/hep.0000000000000004 · Cited by 3,383
Naghavi, M., Ong, K. L., Aali, A., Ababneh, H. S., Abate, Y. H., Abbafati, C., Abbasgholizadeh, R., Abbasian, M., Abbasi-Kangevari, M., Abbastabar, H., et al. (2024) · The Lancet · doi:10.1016/s0140-6736(24)00367-2 · Cited by 2,889
Self-citationLo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Global burden of primary liver cancer in 2020 and predictions to 2040
Rumgay, H., Arnold, M., Ferlay, J., Lesi, O., Cabasag, C. J., Vignat, J., Laversanne, M., McGlynn, K. A., & Soerjomataram, I. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.08.021 · Cited by 2,197
Omata, M., Cheng, A.-L., Kokudo, N., Kudo, M., Lee, J. M., Jia, J., Tateishi, R., Han, K.-H., Chawla, Y. K., Shiina, S., et al. (2017) · Hepatology International · doi:10.1007/s12072-017-9799-9 · Cited by 2,171
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma
Singal, A. G., Llovet, J. M., Yarchoan, M., Mehta, N., Heimbach, J. K., Dawson, L. A., Jou, J. H., Kulik, L. M., Agopian, V. G., Marrero, J. A., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000466 · Cited by 2,052
Self-citationFinn, R. S., Ryoo, B.-Y., Merle, P., Kudo, M., Bouattour, M., Lim, H. Y., Breder, V., Edeline, J., Chao, Y., Ogasawara, S., et al. (2020) · Journal of Clinical Oncology · doi:10.1200/jco.19.01307 · Cited by 1,789
Zhu, A. X., Kang, Y.-K., Yen, C.-J., Finn, R. S., Galle, P. R., Llovet, J. M., Assenat, E., Brandi, G., Pracht, M., Lim, H. Y., et al. (2019) · The Lancet Oncology · doi:10.1016/s1470-2045(18)30937-9 · Cited by 1,662
Tremelimumab plus durvalumab in unresectable hepatocellular carcinoma
Abou-Alfa, G. K., Lau, G., Kudo, M., Chan, S. L., Kelley, R. K., Furuse, J., Sukeepaisarnjaroen, W., Kang, Y.-K., Van Dao, T., De Toni, E. N., et al. (2022) · NEJM Evidence · doi:10.1056/evidoa2100070 · Cited by 1,576
Self-citationMutational hot spot in the p53 gene in human hepatocellular carcinomas
Hsu, I. C., Metcalf, R. A., Sun, T., Welsh, J. A., Wang, N. J., & Harris, C. C. (1991) · Nature · doi:10.1038/350427a0 · Cited by 1,534
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
From NASH to HCC: current concepts and future challenges
Anstee, Q. M., Reeves, H. L., Kotsiliti, E., Govaere, O., & Heikenwalder, M. (2019) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0145-7 · Cited by 1,392
Nonalcoholic Steatohepatitis: A Review
Sheka, A. C., Adeyi, O., Thompson, J., Hameed, B., Crawford, P. A., & Ikramuddin, S. (2020) · JAMA · doi:10.1001/jama.2020.2298 · Cited by 1,379
Yau, T., Kang, Y.-K., Kim, T.-Y., El-Khoueiry, A. B., Santoro, A., Sangro, B., Melero, I., Kudo, M., Hou, M.-M., Matilla, A., et al. (2020) · JAMA Oncology · doi:10.1001/jamaoncol.2020.4564 · Cited by 1,273
Tzartzeva, K., Obi, J., Rich, N. E., Parikh, N. D., Marrero, J. A., Yopp, A., Waljee, A. K., & Singal, A. G. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.01.064 · Cited by 1,207
Self-citationBruix, J., Takayama, T., Mazzaferro, V., Chau, G.-Y., Yang, J., Kudo, M., Cai, J., Poon, R. T., Han, K.-H., Tak, W. Y., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00198-9 · Cited by 1,120
Self-citationLivraghi, T., Meloni, F., Di Stasi, M., Rolle, E., Solbiati, L., Tinelli, C., & Rossi, S. (2008) · Hepatology · doi:10.1002/hep.21933 · Cited by 1,103
Mechanisms of HBV-induced hepatocellular carcinoma
Levrero, M., & Zucman-Rossi, J. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.02.021 · Cited by 1,052
Michelotti, G. A., Machado, M. V., & Diehl, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.183 · Cited by 974
Singal, A. G., Kanwal, F., & Llovet, J. M. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00825-3 · Cited by 951
Self-citationRisk of Hepatocellular Cancer in HCV Patients Treated With Direct-Acting Antiviral Agents
Kanwal, F., Kramer, J., Asch, S. M., Chayanupatkul, M., Cao, Y., & El-Serag, H. B. (2017) · Gastroenterology · doi:10.1053/j.gastro.2017.06.012 · Cited by 931
Lencioni, R., Cioni, D., Crocetti, L., Franchini, C., Pina, C. D., Lera, J., & Bartolozzi, C. (2005) · Radiology · doi:10.1148/radiol.2343040350 · Cited by 867
Tumour evolution in hepatocellular carcinoma
Craig, A. J., von Felden, J., Garcia-Lezana, T., Sarcognato, S., & Villanueva, A. (2020) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-019-0229-4 · Cited by 823
SINGAL, A., VOLK, M. L., WALJEE, A., SALGIA, R., HIGGINS, P., ROGERS, M. A. M., & MARRERO, J. A. (2009) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2009.04014.x · Cited by 819
Self-citationTremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
Duffy, A. G., Ulahannan, S. V., Makorova-Rusher, O., Rahma, O., Wedemeyer, H., Pratt, D., Davis, J. L., Hughes, M. S., Heller, T., ElGindi, M., et al. (2017) · Journal of Hepatology · doi:10.1016/j.jhep.2016.10.029 · Cited by 819
Qin, S., Chan, S. L., Gu, S., Bai, Y., Ren, Z., Lin, X., Chen, Z., Jia, W., Jin, Y., Guo, Y., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)00961-3 · Cited by 746
Global Incidence and Prevalence of Nonalcoholic Fatty Liver Disease
Teng, M. L., Ng, C. H., Huang, D. Q., Chan, K. E., Tan, D. J., Lim, W. H., Yang, J. D., Tan, E., & Muthiah, M. D. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0365 · Cited by 727
Self-citationPimpin, L., Cortez-Pinto, H., Negro, F., Corbould, E., Lazarus, J. V., Webber, L., & Sheron, N. (2018) · Journal of Hepatology · doi:10.1016/j.jhep.2018.05.011 · Cited by 710
Yau, T., Tang, V. Y. F., Yao, T.-J., Fan, S.-T., Lo, C.-M., & Poon, R. T. P. (2014) · Gastroenterology · doi:10.1053/j.gastro.2014.02.032 · Cited by 698
Salem, R., Gordon, A. C., Mouli, S., Hickey, R., Kallini, J., Gabr, A., Mulcahy, M. F., Baker, T., Abecassis, M., Miller, F. H., et al. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.08.029 · Cited by 691
Mittal, S., El-Serag, H. B., Sada, Y. H., Kanwal, F., Duan, Z., Temple, S., May, S. B., Kramer, J. R., Richardson, P. A., & Davila, J. A. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.07.019 · Cited by 648
Raoul, J.-L., Forner, A., Bolondi, L., Cheung, T. T., Kloeckner, R., & de Baere, T. (2019) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2018.11.002 · Cited by 643
Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Yeh, S.-H., Chen, P.-J., Iloeje, U. H., Jen, C.-L., Su, J., Wang, L.-Y., Lu, S.-N., You, S.-L., Chen, D.-S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn243 · Cited by 580
Noureddin, M., Vipani, A., Bresee, C., Todo, T., Kim, I. K., Alkhouri, N., Setiawan, V. W., Tran, T., Ayoub, W. S., Lu, S. C., et al. (2018) · American Journal of Gastroenterology · doi:10.1038/s41395-018-0088-6 · Cited by 578
Yao, F. Y., Xiao, L., Bass, N. M., Kerlan, R., Ascher, N. L., & Roberts, J. P. (2007) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2007.01965.x · Cited by 562
Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
Salem, R., Johnson, G. E., Kim, E., Riaz, A., Bishay, V., Boucher, E., Fowers, K., Lewandowski, R., & Padia, S. A. (2021) · Hepatology · doi:10.1002/hep.31819 · Cited by 555
Qin, S., Chen, M., Cheng, A.-L., Kaseb, A. O., Kudo, M., Lee, H. C., Yopp, A. C., Zhou, J., Wang, L., Wen, X., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01796-8 · Cited by 545
Huang, D. Q., Singal, A. G., Kono, Y., Tan, D. J. H., El-Serag, H. B., & Loomba, R. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.05.003 · Cited by 534
Self-citationRadiofrequency versus Microwave Ablation in a Hepatic Porcine Model
Wright, A. S., Sampson, L. A., WARNER, T. F. C. S., Mahvi, D. M., & Lee, F. T. (2005) · Radiology · doi:10.1148/radiol.2361031249 · Cited by 493
Kokudo, T., Hasegawa, K., Matsuyama, Y., Takayama, T., Izumi, N., Kadoya, M., Kudo, M., Ku, Y., Sakamoto, M., Nakashima, O., et al. (2016) · Journal of Hepatology · doi:10.1016/j.jhep.2016.05.044 · Cited by 491
Singal, A. G., Zhang, E., Narasimman, M., Rich, N. E., Waljee, A. K., Hoshida, Y., Yang, J. D., Reig, M., Cabibbo, G., Nahon, P., et al. (2022) · Journal of Hepatology · doi:10.1016/j.jhep.2022.01.023 · Cited by 451
Self-citationYoon, S. M., Ryoo, B.-Y., Lee, S. J., Kim, J. H., Shin, J. H., An, J. H., Lee, H. C., & Lim, Y.-S. (2018) · JAMA Oncology · doi:10.1001/jamaoncol.2017.5847 · Cited by 446
Brissot, P., Pietrangelo, A., Adams, P. C., de Graaff, B., McLaren, C. E., & Loréal, O. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.16 · Cited by 430
Recurrence after liver resection for hepatocellular carcinoma: Risk factors, treatment, and outcomes
Shah, S. A., Cleary, S. P., Wei, A. C., Yang, I., Taylor, B. R., Hemming, A. W., Langer, B., Grant, D. R., Greig, P. D., & Gallinger, S. (2007) · Surgery · doi:10.1016/j.surg.2006.06.028 · Cited by 420
New advances in the diagnosis and management of hepatocellular carcinoma
Yang, J. D., & Heimbach, J. K. (2020) · BMJ · doi:10.1136/bmj.m3544 · Cited by 384
Self-citationBrown, K. T., Do, R. K., Gonen, M., Covey, A. M., Getrajdman, G. I., Sofocleous, C. T., Jarnagin, W. R., D’Angelica, M. I., Allen, P. J., Erinjeri, J. P., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0821 · Cited by 380
Self-citationPopulation attributable risk of aflatoxin-related liver cancer: Systematic review and meta-analysis
Liu, Y., Chang, C.-C. H., Marsh, G. M., & Wu, F. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.02.009 · Cited by 372
Ho, W. J., Zhu, Q., Durham, J., Popovic, A., Xavier, S., Leatherman, J., Mohan, A., Mo, G., Zhang, S., Gross, N., et al. (2021) · Nature Cancer · doi:10.1038/s43018-021-00234-4 · Cited by 360
Lu, D. S. K., Yu, N. C., Raman, S. S., Lassman, C., Tong, M. J., Britten, C., Durazo, F., Saab, S., Han, S., Finn, R., et al. (2005) · Hepatology · doi:10.1002/hep.20688 · Cited by 355
Kang, J., Kim, M., Cho, C. K., Yang, K. M., Yoo, H. J., Kim, J. H., Bae, S. H., Jung, D. H., Kim, Lee, D. H., et al. (2012) · Cancer · doi:10.1002/cncr.27533 · Cited by 334
Wolf, E., Rich, N. E., Marrero, J. A., Parikh, N. D., & Singal, A. G. (2021) · Hepatology · doi:10.1002/hep.31309 · Cited by 333
Self-citationMajno, P. E., Sarasin, F. P., Mentha, G., & Hadengue, A. (2000) · Hepatology · doi:10.1053/he.2000.5763 · Cited by 326
Berhane, S., Toyoda, H., Tada, T., Kumada, T., Kagebayashi, C., Satomura, S., Schweitzer, N., Vogel, A., Manns, M. P., Benckert, J., et al. (2016) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2015.12.042 · Cited by 323
Systemic Therapy for Advanced Hepatocellular Carcinoma: ASCO Guideline Update
Gordan, J. D., Kennedy, E. B., Abou-Alfa, G. K., Beal, E., Finn, R. S., Gade, T. P., Goff, L., Gupta, S., Guy, J., Hoang, H. T., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.23.02745 · Cited by 312
Self-citationSynergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis
Kew, M. C. (2003) · Liver International · doi:10.1111/j.1478-3231.2003.00869.x · Cited by 302
Transarterial Chemoembolization Failure/Refractoriness: JSH-LCSGJ Criteria 2014 Update
Kudo, M., Matsui, O., Izumi, N., Kadoya, M., Okusaka, T., Miyayama, S., Yamakado, K., Tsuchiya, K., Ueshima, K., Hiraoka, A., et al. (2014) · Oncology · doi:10.1159/000368142 · Cited by 283
Zimmerman, M. A. (2008) · Archives of Surgery · doi:10.1001/archsurg.2007.39 · Cited by 278
Kaseb, A. O., Hasanov, E., Cao, H. S. T., Xiao, L., Vauthey, J.-N., Lee, S. S., Yavuz, B. G., Mohamed, Y. I., Qayyum, A., Jindal, S., et al. (2022) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(21)00427-1 · Cited by 274
Wang, C., Wang, H., Yang, W., Hu, K., Xie, H., Hu, K., Bai, W., Dong, Z., Lu, Y., Zeng, Z., et al. (2015) · Hepatology · doi:10.1002/hep.27548 · Cited by 272
Qin, S., Kudo, M., Meyer, T., Bai, Y., Guo, Y., Meng, Z., Satoh, T., Marino, D., Assenat, E., Li, S., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.4003 · Cited by 265
Aflatoxins as a cause of hepatocellular carcinoma.
Kew, M. C. (2013) · PubMed · Cited by 263
Mittal, S., Sada, Y. H., El-Serag, H. B., Kanwal, F., Duan, Z., Temple, S., May, S. B., Kramer, J. R., Richardson, P. A., & Davila, J. A. (2015) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2014.08.013 · Cited by 261
Liu, J., Ayada, I., Zhang, X., Wang, L., Li, Y., Wen, T., Ma, Z., Bruno, M. J., de Knegt, R. J., Cao, W., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.02.030 · Cited by 242
Kim, T. H., Koh, Y. H., Kim, B. H., Kim, M. J., Lee, J. H., Park, B., & Park, J.-W. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.026 · Cited by 230
Diagnosis and management of autoimmune hepatitis
Muratori, L., Lohse, A. W., & Lenzi, M. (2023) · BMJ · doi:10.1136/bmj-2022-070201 · Cited by 230
Tayob, N., Kanwal, F., Alsarraj, A., Hernaez, R., & El-Serag, H. B. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.01.047 · Cited by 228
Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments
Peng, C., Stewart, A. G., Woodman, O. L., Ritchie, R. H., & Qin, C. X. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.603926 · Cited by 225
Reddy, S. K., Steel, J. L., Chen, H.-W., DeMateo, D. J., Cardinal, J., Behari, J., Humar, A., Marsh, W. J., Geller, D. A., & Tsung, A. (2012) · Hepatology · doi:10.1002/hep.25536 · Cited by 224
Yang, J. D., Addissie, B. D., Mara, K. C., Harmsen, W. S., Dai, J., Zhang, N., Wongjarupong, N., Ali, H. M., Ali, H. A., Hassan, F. A., et al. (2019) · Cancer Epidemiology, Biomarkers & Prevention · doi:10.1158/1055-9965.epi-18-0281 · Cited by 222
Self-citationMatsui, O., Kobayashi, S., Sanada, J., Kouda, W., Ryu, Y., Kozaka, K., Kitao, A., Nakamura, K., & Gabata, T. (2011) · Abdominal Imaging · doi:10.1007/s00261-011-9685-1 · Cited by 219
Hyun, M. H., Lee, Y., Kim, J. H., Lee, C. U., Jung, Y. K., Seo, Y. S., Yim, H. J., Yeon, J. E., & Byun, K. S. (2018) · Hepatology · doi:10.1002/hep.29883 · Cited by 219
Why does living donor liver transplantation flourish in Asia?
Chen, C.-L., Kabiling, C. S., & Concejero, A. M. (2013) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2013.194 · Cited by 218
Kisiel, J. B., Dukek, B. A., V.S.R. Kanipakam, R., Ghoz, H. M., Yab, T. C., Berger, C. K., Taylor, W. R., Foote, P. H., Giama, N. H., Onyirioha, K., et al. (2019) · Hepatology · doi:10.1002/hep.30244 · Cited by 210
The intersection between alcohol-related liver disease and nonalcoholic fatty liver disease
Díaz, L. A., Arab, J. P., Louvet, A., Bataller, R., & Arrese, M. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00822-y · Cited by 207
Dhondt, E., Lambert, B., Hermie, L., Huyck, L., Vanlangenhove, P., Geerts, A., Verhelst, X., Aerts, M., Vanlander, A., Berrevoet, F., et al. (2022) · Radiology · doi:10.1148/radiol.211806 · Cited by 205
AGA Clinical Practice Guideline on Systemic Therapy for Hepatocellular Carcinoma
Su, G. L., Altayar, O., O’Shea, R., Shah, R., Estfan, B., Wenzell, C., Sultan, S., & Falck-Ytter, Y. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.276 · Cited by 201
Kim, J. U., Majid, A., Judge, R., Crook, P., Nathwani, R., Selvapatt, N., Lovendoski, J., Manousou, P., Thursz, M., Dhar, A., et al. (2020) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(20)30251-x · Cited by 199
Hepatocellular carcinoma surveillance — utilization, barriers and the impact of changing aetiology
Huang, D. Q., Singal, A. G., Kanwal, F., Lampertico, P., Buti, M., Sirlin, C. B., Nguyen, M. H., & Loomba, R. (2023) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00818-8 · Cited by 189
Self-citationTen-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma
Tabrizian, P., Holzner, M. L., Mehta, N. J., Halazun, K. J., Agopian, V. G., Yao, F. Y., Busuttil, R. W., Roberts, J. P., Emond, J. C., Samstein, B., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.2800 · Cited by 187
Self-citationMak, L.-Y., Liu, K., Chirapongsathorn, S., Yew, K. C., Tamaki, N., Rajaram, R. B., Panlilio, M. T., Lui, R., Lee, H. W., Lai, J. C.-T., et al. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00967-4 · Cited by 182
Danpanichkul, P., Suparan, K., Tothanarungroj, P., Dejvajara, D., Rakwong, K., Pang, Y., Barba, R., Thongpiya, J., Fallon, M. B., Harnois, D. M., et al. (2024) · Gut · doi:10.1136/gutjnl-2024-333227 · Cited by 182
Self-citationAbbreviated MRI for hepatocellular carcinoma screening: A systematic review and meta-analysis
Gupta, P., Soundararajan, R., Patel, A., Kumar-M, P., Sharma, V., & Kalra, N. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2021.01.041 · Cited by 178
Recent advances in the management of hepatocellular carcinoma
Sankar, K. N., Gong, J., Osipov, A., Miles, S. A., Kosari, K., Nissen, N. N., Hendifar, A. E., Koltsova, E. K., & Yang, J. D. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2023.0125 · Cited by 178
Self-citationLin, C.-W., Lin, C.-C., Mo, L.-R., Chang, C.-Y., Perng, D.-S., Hsu, C.-C., Lo, G.-H., Chen, Y.-S., Yen, Y.-C., Hu, J.-T., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2012.11.045 · Cited by 174
Shiina, S., Sato, K., Tateishi, R., Shimizu, M., Ohama, H., Hatanaka, T., Takawa, M., Nagamatsu, H., & Imai, Y. (2018) · Canadian Journal of Gastroenterology and Hepatology · doi:10.1155/2018/4756147 · Cited by 173
GALAD demonstrates high sensitivity for HCC surveillance in a cohort of patients with cirrhosis
Singal, A. G., Tayob, N., Mehta, A., Marrero, J. A., El‐Serag, H., Jin, Q., Saenz de Viteri, C., Fobar, A., & Parikh, N. D. (2022) · Hepatology · doi:10.1002/hep.32185 · Cited by 173
Self-citationCost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms
Parikh, N. D., Singal, A. G., Hutton, D. W., & Tapper, E. B. (2020) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000000715 · Cited by 163
Self-citationAlcohol Consumption: Medical Implications, the Liver and Beyond
Meza, V., Arnold, J., Díaz, L. A., Ayala-Valverde, M., Idalsoaga, F. J., Ayares, G., Devuni, D., & Arab, J. P. (2022) · Alcohol and Alcoholism · doi:10.1093/alcalc/agac013 · Cited by 163
Lencioni, R., Kudo, M., Erinjeri, J., Qin, S., Ren, Z., Chan, S., Arai, Y., Heo, J., Mai, A., Escobar, J., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.2024.42.3_suppl.lba432 · Cited by 161
Jin, Z.-C., Chen, J.-J., Zhu, X.-L., Duan, X.-H., Xin, Y.-J., Zhong, B.-Y., Chen, J.-Z., Tie, J., Zhu, K.-S., Zhang, L., et al. (2024) · eClinicalMedicine · doi:10.1016/j.eclinm.2024.102622 · Cited by 161
Chalasani, N. P., Porter, K., Bhattacharya, A., Book, A. J., Neis, B. M., Xiong, K. M., Ramasubramanian, T. S., Edwards, D. K., Chen, I., Johnson, S., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.08.010 · Cited by 159
Self-citationSafety and Efficacy of Robotic vs Open Liver Resection for Hepatocellular Carcinoma
Benedetto, F. D., Magistri, P., Sandro, S. D., Sposito, C., Oberkofler, C. E., Brandon, E., Samstein, B., Guidetti, C., Papageorgiou, A., Frassoni, S., et al. (2022) · JAMA Surgery · doi:10.1001/jamasurg.2022.5697 · Cited by 158
Mehta, N., Frenette, C., Tabrizian, P., Hoteit, M., Guy, J., Parikh, N., Ghaziani, T. T., Dhanasekaran, R., Dodge, J. L., Natarajan, B., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.07.033 · Cited by 154
Self-citationGalle, P. R., Decaens, T., Kudo, M., Qin, S., Fonseca, L., Sangro, B., Karachiwala, H., Park, J., Gane, E. J., Pinter, M., et al. (2024) · Journal of Clinical Oncology · doi:10.1200/jco.2024.42.17_suppl.lba4008 · Cited by 152
Reig, M., Darnell, A., Forner, A., Rimola, J., Ayuso, C., & Bruix, J. (2014) · Seminars in Liver Disease · doi:10.1055/s-0034-1394143 · Cited by 149
Singal, A. G., Tiro, J. A., Murphy, C. C., Blackwell, J.-M., Kramer, J. R., Khan, A., Liu, Y., Zhang, S., Phillips, J. L., & Hernáez, R. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.06.049 · Cited by 146
Self-citationRisk stratification and early detection biomarkers for precision HCC screening
Lee, Y., Fujiwara, N., Yang, J. D., & Hoshida, Y. (2022) · Hepatology · doi:10.1002/hep.32779 · Cited by 145
Self-citationLiquid biopsy in the clinical management of hepatocellular carcinoma
von Felden, J., Garcia-Lezana, T., Schulze, K., Losic, B., & Villanueva, A. (2020) · Gut · doi:10.1136/gutjnl-2019-320282 · Cited by 141
Effects of the COVID-19 pandemic and lockdown on alcohol use disorders and complications
Murthy, P., & Narasimha, V. L. (2021) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000720 · Cited by 139
Schoenberger, H., Chong, N., Fetzer, D. T., Rich, N. E., Yokoo, T., Khatri, G., Olivares, J., Parikh, N. D., Yopp, A. C., Marrero, J. A., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.06.012 · Cited by 139
Self-citationThe Role of Aflatoxins in Hepatocellular Carcinoma
Wu, H.-C., & Santella, R. M. (2012) · Hepatitis Monthly · doi:10.5812/hepatmon.7238 · Cited by 135
Hepatitis B Treatment: What We Know Now and What Remains to Be Researched
Lok, A. S.-F. (2018) · Hepatology Communications · doi:10.1002/hep4.1281 · Cited by 135
Tseng, T., Liu, C., Hsu, C.-Y., Hong, C., Su, T., Yang, W., Chen, C., Yang, H., Huang, Y., Kuo, S. F., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2019.08.028 · Cited by 134
Negro, F., & Lok, A. S.-F. (2023) · JAMA · doi:10.1001/jama.2023.23242 · Cited by 134
Primary Care Provider Practice Patterns and Barriers to Hepatocellular Carcinoma Surveillance
Simmons, O. L., Feng, Y., Parikh, N. D., & Singal, A. G. (2018) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2018.07.029 · Cited by 132
Self-citationTrevisani, F., Santi, V., Gramenzi, A., Nolfo, M. A. D., Poggio, P. D., Benvegnù, L., Rapaccini, G., Farinati, F., Zoli, M., Borzio, F., et al. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01395.x · Cited by 131
Facciorusso, A., Aziz, M. A. A. E., Tartaglia, N., Ramai, D., Mohan, B. P., Cotsoglou, C., Pusceddu, S., Giacomelli, L., Ambrosi, A., & Sacco, R. (2020) · Cancers · doi:10.3390/cancers12123796 · Cited by 131
Soini, Y., Chia, S.-C., Bennett, W. P., Groopman, J. D., Wang, J.-S., DeBenedetti, V. M. G., Cawley, H., Welsh, J.-A., Hansen, C., Bergasa, N. V., et al. (1996) · Carcinogenesis · doi:10.1093/carcin/17.5.1007 · Cited by 128
Fulgenzi, C. A. M., Cheon, J., D’Alessio, A., Nishida, N., Ang, C., Marron, T. U., Wu, L. Y., Saeed, A., Wietharn, B., Cammarota, A., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2022.08.024 · Cited by 113
Self-citationHepatitis C Virus–Associated Cancer
Lin, M. V., King, L. Y., & Chung, R. T. (2014) · Annual Review of Pathology Mechanisms of Disease · doi:10.1146/annurev-pathol-012414-040323 · Cited by 111
Curative Irradiation Treatment of Hepatocellular Carcinoma: A Multicenter Phase 2 Trial
Durand-Labrunie, J., Baumann, A.-S., Ayav, A., Laurent, V., Boleslawski, E., Cattan, S., Bogart, E., Deley, M. L., Steen, V., Lacornerie, T., et al. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2019.12.004 · Cited by 111
Xie, E., Yeo, Y. H., Scheiner, B., Zhang, Y., Hiraoka, A., Tantai, X., Fessas, P., de Castro, T., D’Alessio, A., Fulgenzi, C. A. M., et al. (2023) · JAMA Oncology · doi:10.1001/jamaoncol.2023.3284 · Cited by 109
Self-citationSun, N., Zhang, C., Lee, Y., Tran, B. V., Wang, J., Kim, H. Y., Lee, J., Zhang, R. Y., Wang, J. J., Hu, J., et al. (2022) · Hepatology · doi:10.1002/hep.32692 · Cited by 104
Self-citationTsilimigras, D. I., Mehta, R., Paredes, A. Z., Moris, D., Sahara, K., Bagante, F., Ratti, F., Marques, H. P., da Silva, S. G., Soubrane, O., et al. (2020) · Annals of Surgery · doi:10.1097/sla.0000000000004346 · Cited by 101
Choi, S., Kim, B. K., Yon, D. K., Lee, S. W., Lee, H. G., Chang, H. H., Park, S., Koyanagi, A., Jacob, L., Dragioti, E., et al. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0316 · Cited by 100
Lin, C., & Kao, J. (2023) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0342 · Cited by 100
[Nonalcoholic steatohepatitis: a review].
Jacquemin, G. (2003) · PubMed · Cited by 98
Nishikawa, H., Inuzuka, T., Takeda, H., Nakajima, J., Matsuda, F., Sakamoto, A., Henmi, S., Hatamaru, K., Ishikawa, T., Saito, S., et al. (2011) · BMC Gastroenterology · doi:10.1186/1471-230x-11-143 · Cited by 95
We know DAA s work, so now what? Simplifying models of care to enhance the hepatitis C cascade
Lazarus, J. V., Pericàs, J. M., Picchio, C. A., Černoša, J., Hoekstra, M., Luhmann, N., Matičič, M., Read, P. J., Robinson, E. M., & Dillon, J. F. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12972 · Cited by 90
Kelley, R. K., Ryoo, B., Merle, P., Park, J., Bolondi, L., Chan, S. L., Lim, H.-Y., Baron, A. D., Parnis, F. X., Knox, J. J., et al. (2020) · ESMO Open · doi:10.1136/esmoopen-2020-000714 · Cited by 90
Self-citationNarasimman, M., Hernáez, R., Cerda, V., Lee, M., Sood, A., Yekkaluri, S., Khan, A., Quirk, L., Liu, Y., Kramer, J. R., et al. (2023) · Hepatology · doi:10.1097/hep.0000000000000528 · Cited by 85
Self-citationThe importance of a multidisciplinary approach to hepatocellular carcinoma
Siddique, O., Yoo, E. R., Perumpail, R. B., Perumpail, B. J., Liu, A., Cholankeril, G. T., & Ahmed, A. (2017) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s128629 · Cited by 83
Kamal, H., Fornes, R., Simin, J., Stal, P. I., Duberg, A., Brusselaers, N., & Aleman, S. (2021) · Journal of Viral Hepatitis · doi:10.1111/jvh.13577 · Cited by 80
Stereotactic body radiation therapy for hepatocellular carcinoma: From infancy to ongoing maturity
Lewis, S. C., Dawson, L. A., Barry, A. S., Stanescu, T., Mohamad, I., & Hosni, A. (2022) · JHEP Reports · doi:10.1016/j.jhepr.2022.100498 · Cited by 80
Huang, D. Q., Tan, D. J. H., Ng, C. H., Amangurbanova, M., Sutter, N., Tay, P. W. L., Lim, W. H., Yong, J. N., Tang, A. S. P., Syn, N. L. X., et al. (2022) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2022.06.032 · Cited by 80
Marshall, A. D., Willing, A., Kairouz, A., Cunningham, E. B., Wheeler, A., O’Brien, N., Perera, V., Ward, J. W., Hiebert, L., Degenhardt, L. J., et al. (2024) · The Lancet. Gastroenterology & hepatology · doi:10.1016/s2468-1253(23)00335-7 · Cited by 78
Palliative care in hepatocellular carcinoma
Laube, R., Sabih, A., Strasser, S. I., Lim, L., Cigolini, M., & Liu, K. (2020) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.15169 · Cited by 75
Kulkarni, A. V., Tevethia, H. V., Kumar, K., Premkumar, M., Muttaiah, M. D., Hiraoka, A., Hatanaka, T., Tada, T., Kumada, T., Kakizaki, S., et al. (2023) · EClinicalMedicine · doi:10.1016/j.eclinm.2023.102179 · Cited by 72
Self-citationDanpanichkul, P., Suparan, K., Dutta, P., Kaeosri, C., Sukphutanan, B., Pang, Y., Kulthamrongsri, N., Jaisa-aad, M., Ng, C. H., Teng, M. L. P., et al. (2024) · Metabolism · doi:10.1016/j.metabol.2024.155958 · Cited by 72
Self-citationPalliative Care for People With Hepatocellular Carcinoma, and Specific Benefits for Older Adults
Woodrell, C. D., Hansen, L., Schiano, T. D., & Goldstein, N. E. (2018) · Clinical Therapeutics · doi:10.1016/j.clinthera.2018.02.017 · Cited by 69
Geh, D., Manas, D., & Reeves, H. L. (2021) · HepatoBiliary Surgery and Nutrition · doi:10.21037/hbsn.2019.08.08 · Cited by 69
Envisioning how to advance the MASH field
Allen, A. M., Younossi, Z. M., Diehl, A. M., Charlton, M., & Lazarus, J. V. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-024-00938-9 · Cited by 68
Yang, J. D., Altekruse, S. F., Nguyen, M. H., Gores, G. J., & Roberts, L. R. (2016) · Cancer · doi:10.1002/cncr.30246 · Cited by 67
Self-citationLim, C., Shinkawa, H., Hasegawa, K., Bhangui, P., Salloum, C., Gómez‐Gavara, C., Lahat, E., Omichi, K., Arita, J., Sakamoto, Y., et al. (2017) · Liver Transplantation · doi:10.1002/lt.24952 · Cited by 66
Hepatocellular Carcinoma Screening Process Failures in Patients with Cirrhosis
Marquardt, P. C., Liu, P., Immergluck, J., Olivares, J., Arroyo, A., Rich, N. E., Parikh, N. D., Yopp, A. C., & Singal, A. G. (2021) · Hepatology Communications · doi:10.1002/hep4.1735 · Cited by 65
Self-citationInequities in primary liver cancer in Europe: The state of play
Kondili, L. A., Lazarus, J. V., Jepsen, P., Murray, F., Schattenberg, J. M., Korenjak, M., Craxì, L., & Buti, M. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2023.12.031 · Cited by 65
Risk of hepatocellular carcinoma after hepatitis C virus cure
Luna‐Cuadros, M. A., Chen, H., Hanif, H., Ali, M. J., Khan, M. M., & Lau, D. (2021) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i1.96 · Cited by 64
Garin, É., Tselikas, L., Guiu, B., Chalaye, J., Rolland, Y., de Baère, T., Assénat, E., Tacher, V., Palard, X., Deandreis, D., et al. (2024) · Journal of Nuclear Medicine · doi:10.2967/jnumed.123.266211 · Cited by 61
Financial Burden of Hepatocellular Carcinoma Screening in Patients With Cirrhosis
Narasimman, M., Hernáez, R., Cerda, V., Lee, M., Yekkaluri, S., Khan, A., Sood, A., Gurley, T., Quirk, L., Liu, Y., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.07.018 · Cited by 59
Self-citationIncidence of liver cancer in young adults according to the Global Burden of Disease database 2019
Danpanichkul, P., Aboona, M. B., Sukphutanan, B., Kongarin, S., Duangsonk, K., Ng, C. H., Muthiah, M. D., Huang, D. Q., Seko, Y., Díaz, L. A., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000872 · Cited by 59
Self-citationPinheiro, P. S., Jones, P. D., Medina, H. N., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.08.016 · Cited by 58
Choi, W., Kim, G., Choi, J., Choi, G. H., Lee, Y. B., Sinn, D. H., & Lim, Y. (2023) · Gut · doi:10.1136/gutjnl-2023-330225 · Cited by 58
Alcohol-related liver disease: A global perspective
Castro‐Narro, G., Díaz, L. A., Ortega, E. K., Garín, M. F. B., Reyes, E. C., Delfin, P. S. M., Arab, J. P., & Bataller, R. A. (2024) · Annals of Hepatology · doi:10.1016/j.aohep.2024.101499 · Cited by 58
Thiele, M. S., Gluud, L. L., Fialla, A. D., Dahl, E., & Krag, A. A. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107177 · Cited by 56
Govalan, R., Lauzon, M., Luu, M., Ahn, J. C., Kosari, K., Todo, T., Kim, I. K., Noureddin, M., Kuo, A., Ayoub, W. S., et al. (2021) · Liver Cancer · doi:10.1159/000515554 · Cited by 56
Self-citationRacial and Ethnic Disparities in Barriers to Care in Patients with Hepatocellular Carcinoma
Schoenberger, H., Rich, N. E., Jones, P. D., Yekkaluri, S., Yopp, A. C., Singal, A. G., Arroyo, A., Figueroa, G., Kopplin, N., Rose, M., et al. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.12.027 · Cited by 56
Self-citationNASH is the Leading Cause of Hepatocellular Carcinoma in Liver Transplant Candidates
Koh, J. H., Ng, C. H., Nah, B. K. Y., Tan, D. J. H., Loomba, R. S., Huang, D. Q., Lim, W. H., Xiao, J., Fu, C., Zeng, R. W., et al. (2023) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2023.05.019 · Cited by 56
Danpanichkul, P., Suparan, K., Kim, D., & Wijarnpreecha, K. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13010278 · Cited by 54
Self-citationHoang, J. K., Yang, H., Le, A. K., Nguyen, N. H., Lin, D., Vu, V. D., Chaung, K. T., Nguyen, V., Trinh, H. N., Li, J., et al. (2016) · Medicine · doi:10.1097/md.0000000000004433 · Cited by 52
HES V2.0 outperforms GALAD for detection of HCC: A phase 3 biomarker study in the United States
El‐Serag, H. B., Jin, Q., Tayob, N., Salem, E., Luster, M., Alsarraj, A., Khaderi, S. A., Singal, A. G., Marrero, J. A., Asrani, S. K., et al. (2024) · Hepatology · doi:10.1097/hep.0000000000000953 · Cited by 49
Self-citationBiopsy for advanced hepatocellular carcinoma: results of a multicentre UK audit
Childs, A., Zakeri, N., Ma, Y. T., O’Rourke, J. M., Ross, P. J., Hashem, E., Hubner, R. A., Hockenhull, K., Iwuji, C., Khan, S., et al. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01535-2 · Cited by 48
Zeng, R. W., Ong, C. E. Y., Ong, E. Y. H., Chung, C. H., Lim, W. H., Xiao, J., Danpanichkul, P., Law, J. H., Syn, N., Chee, D., et al. (2024) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2024.06.026 · Cited by 47
Self-citationLiang, L., Chen, T., Li, C., Xing, H., Han, J. S., Wang, M.-D., Zhang, H., Lau, W. Y., Wu, M., Shen, F., et al. (2018) · HPB · doi:10.1016/j.hpb.2018.06.1804 · Cited by 47
Vitale, A., Romano, P., Cillo, U., Writing Group for the HE.RC.O.LE.S Collaborative Group, Writing Group for the ITA.LI.CA Collaborative Group, Groups, H. R. O. L. S. A. I. L. C. C., Busti, M., Nezi, G., Carlis, R. D., Ratti, F., et al. (2024) · JAMA Surgery · doi:10.1001/jamasurg.2024.1184 · Cited by 47
Pitfalls in surveillance for hepatocellular carcinoma: How successful is it in the real world?
Wong, L. L., Reyes, R., Kwee, S. A., Hernandez, B. Y., Kalathil, S. C., & Tsai, N. C. S. (2017) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2017.0008 · Cited by 46
de Sousa, J. H. B., Calil, I. L., Tustumi, F., Khalil, D. D. C., Felga, G. E. G., Pécora, R. A. A., & de Almeida, M. D. (2020) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.01.06 · Cited by 46
Huang, Z., Lu, G., Qiu, L., Zhong, G., Huang, Y., Yao, X., Liu, X., Huang, S., Wu, T., Yuan, Q., et al. (2022) · BMC Cancer · doi:10.1186/s12885-022-09413-7 · Cited by 45
Changes in the epidemiological trends of primary liver cancer in the Asia–Pacific region
Danpanichkul, P., Suparan, K., Sukphutanan, B., Kaeosri, C., Tothanarungroj, P., Sirimangklanurak, S., Kalligeros, M., Polpichai, N., Pang, Y., Wijarnpreecha, K., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-70526-z · Cited by 45
Self-citationNatural History of Non-Alcoholic Fatty Liver Disease: A Study With Paired Liver Biopsies
Reddy, Y. K., Marella, H. K., Jiang, Y., Ganguli, S., Snell, P. D., Podila, P. S. B., Maliakkal, B. J., & Satapathy, S. K. (2019) · Journal of Clinical and Experimental Hepatology · doi:10.1016/j.jceh.2019.07.002 · Cited by 44
Elkomos, B. E., Abdo, M., Mamdouh, R., & Abdelaal, A. K. (2022) · Hepatology International · doi:10.1007/s12072-022-10435-3 · Cited by 42
Hagström, H., Thiele, M. S., Sharma, R., Simon, T. G., Roelstraete, B., Söderling, J. K., & Ludvigsson, J. F. (2021) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2021.01.005 · Cited by 41
The Use of ctDNA in the Diagnosis and Monitoring of Hepatocellular Carcinoma—Literature Review
Kopystecka, A., Patryn, R. K., Leśniewska, M., Budzyńska, J., & Kozioł, I. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24119342 · Cited by 40
Tayob, N., Corley, D. A., Christie, I. C., Almers, L. M., Rahal, A. K., Richardson, P., White, D. L., Davila, J. A., Kanwal, F., & El‐Serag, H. B. (2020) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2020.07.065 · Cited by 39
Armandi, A., & Bugianesi, E. (2021) · Liver International · doi:10.1111/liv.14910 · Cited by 38
Kao, S. Z., Sangha, K., Fujiwara, N., Hoshida, Y., Parikh, N. D., & Singal, A. G. (2024) · EClinicalMedicine · doi:10.1016/j.eclinm.2024.102755 · Cited by 38
Self-citationDifferences between hepatocellular carcinoma caused by alcohol and other aetiologies
Ganne‐Carrié, N., & Nahon, P. (2024) · Journal of Hepatology · doi:10.1016/j.jhep.2024.12.030 · Cited by 38
Alcohol and HCV: Implications for Liver Cancer
Szabó, G., Saha, B., & Bukong, T. N. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-09614-8_12 · Cited by 37
Danpanichkul, P., Chen, V. L., Chaiyakunapruk, N., Auttapracha, T., Kongarin, S., Ng, C. H., Duangsonk, K., Muthiah, M. D., Sukphutanan, B., Sim, B., et al. (2024) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.18095 · Cited by 37
Self-citationDanpanichkul, P., Ng, C. H., Muthiah, M. D., Duangsonk, K., Yong, J. N., Tan, D. J. H., Lim, W. H., Wong, Z. Y., Syn, N. L. X., Tsusumi, T., et al. (2023) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.17714 · Cited by 35
Self-citationSingal, A. G., Ghaziani, T., Mehta, N. J., Zhou, K., Grinspan, L. T., Benhammou, J. N., Moon, A. M., Yang, J. D., Salgia, R. J., Pillai, A. A., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000073 · Cited by 34
Self-citationOh, J. H., & Sinn, D. H. (2024) · Journal of Liver Cancer · doi:10.17998/jlc.2024.02.27 · Cited by 34
Hepatocellular carcinoma surveillance in patients with non-alcoholic fatty liver disease
Dahan, K. S. E., Daher, D., & Singal, A. G. (2022) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2022.0247 · Cited by 33
Self-citationRadiofrequency ablation of hepatocellular carcinoma: Current status, challenges, and prospects
Wang, H., Wu, Z., Cui, D., Shi, Y., & Zhai, B. (2023) · Liver Research · doi:10.1016/j.livres.2023.05.002 · Cited by 32
Alcohol use disorder in alcohol-associated liver disease: Two sides of the same coin
Singal, A. K., Leggio, L., & DiMartini, A. F. (2023) · Liver Transplantation · doi:10.1097/lvt.0000000000000296 · Cited by 31
Self-citationIntegrating social nutrition principles into the treatment of steatotic liver disease
Wajcman, D. I., Brennan, P., Kopka, C. J., Zelber‐Sagi, S., Younossi, Z. M., Allen, A. M., Flórez, K. R., & Lazarus, J. V. (2023) · Communications Medicine · doi:10.1038/s43856-023-00398-3 · Cited by 31
Hepatocellular Carcinoma Screening in a Contemporary Cohort of At-Risk Patients
Daher, D., Dahan, K. S. E., Rich, N. E., Tayob, N., Merrill, V., Huang, D. Q., Yang, J. D., Kulkarni, A. V., Kanwal, F., Marrero, J. A., et al. (2024) · JAMA Network Open · doi:10.1001/jamanetworkopen.2024.8755 · Cited by 31
Self-citationKim, G., Lim, Y., Han, S., Choi, G. H., Choi, W.-M., Choi, J., Sinn, D. H., Paik, Y., Lee, J., Lee, Y. B., et al. (2024) · Annals of Internal Medicine · doi:10.7326/m24-0384 · Cited by 31
Danpanichkul, P., Auttapracha, T., Sukphutanan, B., Ng, C. H., Wattanachayakul, P., Kongarin, S., Dutta, P., Duangsonk, K., Thongpiya, J., Muthiah, M. D., et al. (2024) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002819 · Cited by 30
Self-citationMortality outcomes in individuals with MASLD versus MASLD and increased alcohol intake
Aboona, M. B., Danpanichkul, P., Chen, V. L., Rangan, P., Kim, D., Alkhouri, N., Fallon, M. B., Noureddin, M., Arab, J. P., & Wijarnpreecha, K. (2024) · Journal of Gastroenterology and Hepatology · doi:10.1111/jgh.16726 · Cited by 29
Self-citationNeoadjuvant systemic therapy for hepatocellular carcinoma
Chick, R. C., Ruff, S. M., & Pawlik, T. M. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1355812 · Cited by 29
Natarajan, B., Tabrizian, P., Hoteit, M. A., Frenette, C. T., Parikh, N. D., Ghaziani, T., Dhanasekaran, R., Guy, J. E., Shui, A. M., Florman, S. S., et al. (2023) · American Journal of Transplantation · doi:10.1016/j.ajt.2023.07.021 · Cited by 28
Self-citationHepatocellular Carcinoma Prevention in the Era of Hepatitis C Elimination
Lazarus, J. V., Picchio, C. A., & Colombo, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241814404 · Cited by 28
Frühling, P., Stillström, D., Holmquist, F., Nilsson, A., & Freedman, J. (2023) · European Journal of Surgical Oncology · doi:10.1016/j.ejso.2023.107046 · Cited by 27
Yang, J., Yang, Z., Zeng, X., Yu, S., Gao, L., Jiang, Y., & Sun, F. (2023) · Journal of the National Cancer Center · doi:10.1016/j.jncc.2023.02.001 · Cited by 26
Self-citationLazarus, J. V., Picchio, C. A., Guy, D., Aleman, S., James, C., Nava, F. A., Øvrehus, A. L. H., Turnés, J., Ward, J. W., & Ustianowski, A. (2021) · Clinics and Research in Hepatology and Gastroenterology · doi:10.1016/j.clinre.2020.11.001 · Cited by 21
Nahon, P., Ronot, M., Sutter, O., Natella, P.-A., Baloul, S., Durand‐Zaleski, I., & Audureau, É. (2024) · BMJ Open · doi:10.1136/bmjopen-2023-083701 · Cited by 18
Sutphin, P. D., Lamus, D., Kalva, S. P., Li, J., & Corbin, I. R. (2019) · Molecular and translational medicine · doi:10.1007/978-3-030-21540-8_9 · Cited by 13
Effects of TACE combined with precise RT on p53 gene expression and prognosis of HCC patients
Liu, Y.-P., Yan, J., & Wang, F. (2018) · Oncology Letters · doi:10.3892/ol.2018.9374 · Cited by 11
Cited by
Wang, Z., Wang, Z., Ji, X., Zhao, L., Zheng, K., Yu, W., Zhang, H., Chang, H., & Liu, F. (2026) · Journal of Translational Medicine · doi:10.1186/s12967-026-08301-z
Metadata
- Authors
- Hwang, S. Y., Danpanichkul, P., Agopian, V., Mehta, N., Parikh, N. D., Abou-Alfa, G. K., Singal, A. G., & Yang, J. D.
- Venue
- Clinical and Molecular Hepatology
- Published
- 2025-02-28
- Volume
- 31
- Issue
- Suppl
- Pages
- S228-S254
- ISSN
- 2287-2728 (ISSN-L)
- 2287-285X
- OpenAlex
- W4405816356
- Cited by
- 306
- References
- 205
- FWCI
- 68.38
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.